| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |